Carisma Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Oct 23 | SellUS$4,665,903 | University of Pennsylvania, Endowment Arm | Company | 930,705 | US$5.01 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 272,481 | 0.656% |
Individual Insiders | 5,111,195 | 12.3% |
VC/PE Firms | 5,843,616 | 14.1% |
Public Companies | 7,809,193 | 18.8% |
Institutions | 9,400,071 | 22.6% |
General Public | 13,105,978 | 31.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
5,059,338 | US$8.2m | 0% | no data | |||
3,398,248 | US$5.5m | 0% | 2.18% | |||
2,749,855 | US$4.5m | 0% | no data | |||
2,445,368 | US$4.0m | -6.93% | no data | |||
2,297,546 | US$3.7m | 0% | no data | |||
2,215,877 | US$3.6m | 0% | no data | |||
1,867,429 | US$3.0m | 6.47% | no data | |||
1,684,062 | US$2.7m | 0% | 0.01% | |||
1,568,761 | US$2.6m | 0.54% | no data | |||
1,252,107 | US$2.0m | -28.9% | 2.58% | |||
515,893 | US$840.9k | 2.4% | no data | |||
500,311 | US$815.5k | 3.77% | no data | |||
484,347 | US$789.5k | 0% | no data | |||
359,168 | US$585.4k | 45% | 0.01% | |||
319,991 | US$521.6k | 0% | 39.25% | |||
267,864 | US$436.6k | 0% | no data | |||
238,916 | US$389.4k | 21.1% | no data | |||
213,034 | US$347.2k | 4.07% | no data | |||
101,250 | US$165.0k | 0% | no data | |||
99,788 | US$162.7k | 0% | no data | |||
81,948 | US$133.6k | 209% | no data | |||
77,712 | US$126.7k | -6.96% | no data | |||
72,743 | US$118.6k | 0% | no data | |||
45,980 | US$74.9k | -74.4% | no data | |||
43,513 | US$70.9k | -19.7% | no data |